Med Life SA
Med Life S.A., a private healthcare provider, provides healthcare services through its clinics and hospitals in Bucharest, Cluj, Braila, Timisoara, Iasi, Galati, Ploiesti, Constanta, and Targu Mures, Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging investigations; day hospitalization services… Read more
Med Life SA (M) - Net Assets
Latest net assets as of September 2025: RON502.03 Million RON
Based on the latest financial reports, Med Life SA (M) has net assets worth RON502.03 Million RON as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RON3.14 Billion) and total liabilities (RON2.64 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | RON502.03 Million |
| % of Total Assets | 15.97% |
| Annual Growth Rate | 17.2% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 16.68 |
Med Life SA - Net Assets Trend (2020–2024)
This chart illustrates how Med Life SA's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Med Life SA (2020–2024)
The table below shows the annual net assets of Med Life SA from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-09-30 | RON507.29 Million | +2.65% |
| 2023-09-30 | RON494.19 Million | +2.52% |
| 2022-09-30 | RON482.04 Million | +26.39% |
| 2021-09-30 | RON381.40 Million | +41.84% |
| 2020-09-30 | RON268.91 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Med Life SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 104.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | RON72.92 Million | 16.83% |
| Other Components | RON360.22 Million | 83.17% |
| Total Equity | RON433.14 Million | 100.00% |
Med Life SA Competitors by Market Cap
The table below lists competitors of Med Life SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kier Group plc
PINK:KIERF
|
$753.42 Million |
|
Wuxi Chipown Micro-electronics Ltd
SHG:688508
|
$754.86 Million |
|
Shenzhen Bluetrum Technology Co. Ltd. A
SHG:688332
|
$754.95 Million |
|
Greggs plc
PINK:GGGSY
|
$754.98 Million |
|
Aerosun Corp
SHG:600501
|
$753.26 Million |
|
Per Aarsleff B
LSE:0REQ
|
$753.20 Million |
|
BIOGAIA AB B O.N.
F:BGLA
|
$752.86 Million |
|
GQG Partners Inc
AU:GQG
|
$752.66 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Med Life SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 415,291,298 to 433,135,378, a change of 17,844,080 (4.3%).
- Net income of 25,545,592 contributed positively to equity growth.
- Share repurchases of 1,078,836 reduced equity.
- Other factors decreased equity by 6,622,676.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | RON25.55 Million | +5.9% |
| Share Repurchases | RON1.08 Million | -0.25% |
| Other Changes | RON-6.62 Million | -1.53% |
| Total Change | RON- | 4.30% |
Book Value vs Market Value Analysis
This analysis compares Med Life SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 13.88x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 23.96x to 13.88x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-09-30 | RON0.47 | RON11.32 | x |
| 2021-09-30 | RON0.66 | RON11.32 | x |
| 2022-09-30 | RON0.82 | RON11.32 | x |
| 2023-09-30 | RON0.79 | RON11.32 | x |
| 2024-09-30 | RON0.82 | RON11.32 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Med Life SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.90%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.94%
- • Asset Turnover: 0.90x
- • Equity Multiplier: 6.98x
- Recent ROE (5.90%) is below the historical average (13.67%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 23.50% | 5.26% | 0.91x | 4.91x | RON32.58 Million |
| 2021 | 30.35% | 7.19% | 1.01x | 4.19x | RON68.80 Million |
| 2022 | 7.72% | 1.79% | 0.83x | 5.16x | RON-9.51 Million |
| 2023 | 0.89% | 0.17% | 0.84x | 6.35x | RON-37.84 Million |
| 2024 | 5.90% | 0.94% | 0.90x | 6.98x | RON-17.77 Million |
Industry Comparison
This section compares Med Life SA's net assets metrics with peer companies in the Medical Care Facilities industry.
No peer company data available for comparison.